Boundless Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.16

+0.07 (+6.42%)

As of Feb 8, 2:23 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +950.9% upside

Low Target $8.12

Average Target $12.19

High Target $14.26

Current Price $1.16

Current
$1.16

Target
$12.19

$8.12 $12.19 avg $14.26

Scenario Analysis

Bear Case

$8.12

600.0%

Low target

Base Case

$12.19

+950.9%

Avg target

Bull Case

$14.26

+1,129.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$13.82

-91.6% from high

52-Week Low

$9.24

+-87.4% from low

Target vs 52W High

$12.19

-11.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%